These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38879606)

  • 1. Spinal muscular atrophy genetic epidemiology and the case for premarital genomic screening in Arab populations.
    Rabea F; El Naofal M; Chekroun I; Khalaf M; Zaabi NA; AlZaabi K; ElHalik M; Dash S; El Saba Y; Ali A; Abraham S; Fathi K; Shekhy J; Aswad SG; Elbashir H; Alkuraya F; Loney T; Alsheikh-Ali A; Khayat AA; Abou Tayoun A
    Commun Med (Lond); 2024 Jun; 4(1):119. PubMed ID: 38879606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic carrier screening for spinal muscular atrophy and spinal muscular atrophy with respiratory distress 1 in an isolated population in Israel.
    Basel-Vanagaite L; Taub E; Drasinover V; Magal N; Brudner A; Zlotogora J; Shohat M
    Genet Test; 2008 Mar; 12(1):53-6. PubMed ID: 18298318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal muscular atrophy carrier frequency in Saudi Arabia.
    Al Jumah M; Al Rajeh S; Eyaid W; Al-Jedai A; Al Mudaiheem H; Al Shehri A; Hussein M; Al Abdulkareem I
    Mol Genet Genomic Med; 2022 Nov; 10(11):e2049. PubMed ID: 36062320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One Year of Newborn Screening for SMA - Results of a German Pilot Project.
    Vill K; Kölbel H; Schwartz O; Blaschek A; Olgemöller B; Harms E; Burggraf S; Röschinger W; Durner J; Gläser D; Nennstiel U; Wirth B; Schara U; Jensen B; Becker M; Hohenfellner K; Müller-Felber W
    J Neuromuscul Dis; 2019; 6(4):503-515. PubMed ID: 31594245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years.
    Vill K; Schwartz O; Blaschek A; Gläser D; Nennstiel U; Wirth B; Burggraf S; Röschinger W; Becker M; Czibere L; Durner J; Eggermann K; Olgemöller B; Harms E; Schara U; Kölbel H; Müller-Felber W
    Orphanet J Rare Dis; 2021 Mar; 16(1):153. PubMed ID: 33789695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a Pilot Newborn Screening Program for Spinal Muscular Atrophy in Saint Petersburg.
    Kiselev A; Maretina M; Shtykalova S; Al-Hilal H; Maslyanyuk N; Plokhih M; Serebryakova E; Frolova M; Shved N; Krylova N; Il'ina A; Freund S; Osinovskaya N; Sultanov I; Egorova A; Lobenskaya A; Koroteev A; Sosnina I; Gorelik Y; Bespalova O; Baranov V; Kogan I; Glotov A
    Int J Neonatal Screen; 2024 Jan; 10(1):. PubMed ID: 38390973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal Muscular Atrophy: Mutations, Testing, and Clinical Relevance.
    Keinath MC; Prior DE; Prior TW
    Appl Clin Genet; 2021; 14():11-25. PubMed ID: 33531827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of Spinal Muscular Atrophy Based on the Results of a Large-Scale Pilot Project on 202,908 Newborns.
    Efimova IY; Zinchenko RA; Marakhonov AV; Balinova NV; Mikhalchuk KA; Shchagina OA; Polyakov AV; Mudaeva DA; Saydaeva DH; Matulevich SA; Parshintseva PD; Belyashova EY; Yakubovskiy GI; Tebieva IS; Gabisova YV; Irinina NA; Jamschikova AV; Nurgalieva LR; Saifullina EV; Nevmerzhitskaya KS; Belyaeva TI; Romanova OS; Voronin SV; Kutsev SI
    Pediatr Neurol; 2024 Jul; 156():147-154. PubMed ID: 38781723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: a prospective population-based cohort study.
    Su YN; Hung CC; Lin SY; Chen FY; Chern JP; Tsai C; Chang TS; Yang CC; Li H; Ho HN; Lee CN
    PLoS One; 2011 Feb; 6(2):e17067. PubMed ID: 21364876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMA Identified: Clinical and Molecular Findings From a Sponsored Testing Program for Spinal Muscular Atrophy in More Than 2,000 Individuals.
    Bowen BM; Truty R; Aradhya S; Bristow SL; Johnson BA; Morales A; Tan CA; Westbrook MJ; Winder TL; Chavez JC
    Front Neurol; 2021; 12():663911. PubMed ID: 34025568
    [No Abstract]   [Full Text] [Related]  

  • 11. Spinal muscular atrophy carriers with two SMN1 copies.
    Ar Rochmah M; Awano H; Awaya T; Harahap NIF; Morisada N; Bouike Y; Saito T; Kubo Y; Saito K; Lai PS; Morioka I; Iijima K; Nishio H; Shinohara M
    Brain Dev; 2017 Nov; 39(10):851-860. PubMed ID: 28676237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copy Number Variations in the Survival Motor Neuron Genes: Implications for Spinal Muscular Atrophy and Other Neurodegenerative Diseases.
    Butchbach ME
    Front Mol Biosci; 2016; 3():7. PubMed ID: 27014701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy.
    Feldkötter M; Schwarzer V; Wirth R; Wienker TF; Wirth B
    Am J Hum Genet; 2002 Feb; 70(2):358-68. PubMed ID: 11791208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newborn and carrier screening for spinal muscular atrophy.
    Prior TW; Snyder PJ; Rink BD; Pearl DK; Pyatt RE; Mihal DC; Conlan T; Schmalz B; Montgomery L; Ziegler K; Noonan C; Hashimoto S; Garner S
    Am J Med Genet A; 2010 Jul; 152A(7):1608-16. PubMed ID: 20578137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Reference Materials for Spinal Muscular Atrophy Genetic Testing: A Genetic Testing Reference Materials Coordination Program Collaborative Project.
    Prior TW; Bayrak-Toydemir P; Lynnes TC; Mao R; Metcalf JD; Muralidharan K; Iwata-Otsubo A; Pham HT; Pratt VM; Qureshi S; Requesens D; Shen J; Vetrini F; Kalman L
    J Mol Diagn; 2021 Jan; 23(1):103-110. PubMed ID: 33197628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemoglobinopathy carrier prevalence in the United Arab Emirates: first analysis of the Dubai Health Authority premarital screening program results.
    Belhoul KM; Abdulrahman M; Alraei RF
    Hemoglobin; 2013; 37(4):359-68. PubMed ID: 23647352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical utility of a risk-modifying SNP to detect carriers for spinal muscular atrophy with increased sensitivity.
    Ware G; Miller C; Jones D; Avenarius M
    Mol Genet Genomic Med; 2022 Apr; 10(4):e1897. PubMed ID: 35289093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of genetic disorders and gene variants in the United Arab Emirates national population: insights from the CTGA database.
    Bizzari S; Nair P; Hana S; Deepthi A; Al-Ali MT; Al-Gazali L; El-Hayek S
    Front Genet; 2023; 14():1177204. PubMed ID: 37214420
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.